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Available online 22 October 2015The management of prostate cancer is rapidly evolving. While
ongoing basic and translational research have led to novel treat-
ment paradigms, many clinicians would agree that acquiring the
right knowledge and skills to improve patient management re-
mains the holy grail of prostate cancer management.
In May 2014 and June 2015, the Academy for Cancer Education
(ACE) organized the Asia Paciﬁc Prostate Cancer Preceptorship
Program at Charite University Medicine Berlin in Berlin, Germany.
Directed by Professor Kurt Miller, Head of the Department of
Urology at Charite, the program aimed to facilitate the sharing of
knowledge, experience and best practice in the management of
localized and advanced prostate cancer.
In addition to formal lectures, the agenda included demon-
strations of contemporary surgical techniques, clinical supervision
and practice, as well as case-based discussions which provided
preceptees with ample opportunities for observation and practice.
Participants of the preceptorship program submitted poster
presentations detailing potential learnings which could be imple-
mented to improve the care of prostate cancer patients in their own
practice or country. A steering committee made up of independent
regional experts selected the three best poster submissions to be
featured at the 4th Asia Paciﬁc Prostate Cancer Conference in Tokyo.
The presentation by Dr Kan Gong from Peking University First
Hospital in China highlighted the differences in the practices to
determine disease staging between Charite Berlin, and his institu-
tion. During the preceptorship program, the advantages of WB-MRI
and PET-CT were highlighted. In particular, PET/CT was superior in
the detection of lymph node metastases. Nevertheless, in the ‘real* Corresponding author: Narin Voravud (narin.voravud@gmail.com).
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p2287-8882 e2287-903Xworld’ setting, MRI remains a useful diagnostic tool. Dr Gong’s team
called for the exploration of newMRI parameters to help diagnosis.
This presentation highlights that even with the advent of novel
imaging technologies, traditional imaging methods continue to
play important roles in decision making in the local context.
Dr Yao Zhu from Fudan University Shanghai Cancer Centre in
China presented on the optimal management of locally advanced
prostate cancer. He compared the differences in management prac-
tices in terms of diagnosis, prognostic evaluation as well as treat-
ment. Dr Zhu highlighted the application of knowledge gained from
the preceptorship program to improve practice in his institution.
Dr Darren Poon from the Prince of Wales Hospital in Hong Kong
shared his experience acquired from attending the program, which
included both surgical and non-surgical aspects in the manage-
ment of advanced prostate cancer. Dr Poon and his MDT partners
from the Prince of Wales Hospital and the Chinese University of
Hong Kongwill pilot a similar experience-based education program
at their institution in January 2016. The main aim of this upcoming
preceptorship is to foster collaborations between urologists and
oncologists in the development of a multidisciplinary approach to
prostate cancer management in the Asia Paciﬁc region.
It is evident, more than ever, that continuing medical education
initiatives such as this preceptorship program are critical to the
development of future leaders in the ﬁeld of genitourinary (GU)
oncology in Asia Paciﬁc. Experience with the preceptor program
has not only provided the much neededmomentum, but important
elements for future GU oncology education activities in the region.Acknowledgments
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